Records containing: Pyoderma Gangrenosum
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-14A Multi-centre, Randomised, Placebo-controlled, Double-blind, Parallel-group Trial to Evaluate Safety and Efficacy of Spesolimab (BI 655130) in Adult Patients With Ulcerative Pyoderma Gangrenosum (PG) Who Require Systemic Therapy
-
CLINICAL_TRIALS study record update · 2026-03-31Characterizing Pyoderma Gangrenosum Lesion Regression and Remission by IL-36 Receptor Targeting With Spesolimab
-
CLINICAL_TRIALS study record update · 2026-03-06A Single-arm Open-label Study Assessing Short-term (Week 6, 16) and Long-term (Week 32) Efficacy of Guselkumab in Adult Participants With Pyoderma Gangrenosum
-
CLINICAL_TRIALS study record update · 2026-03-03A Phase II Clinical Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 Injection in Adult Patients With Pyoderma Gangrenosum
-
CLINICAL_TRIALS study record update · 2026-01-13A Clinical Study Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Ulcerative Pyoderma Gangrenosum
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-07Emerging Indications for Hyperbaric Oxygen Treatment
-
CLINICAL_TRIALS study record update · 2025-11-04A Randomized, Double-blind, Placebo-controlled, Multicenter, Adaptive Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in the Treatment of Ulcerative Pyoderma Gangrenosum
-
CLINICAL_TRIALS study record update · 2025-10-15A Novel Therapeutic Treatment of Pyoderma Gangrenosum
-
CLINICAL_TRIALS study record update · 2025-08-11A Prospective, Open-label, Randomized, Split-ulcer Trial to Evaluate the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Chronic Pyoderma Gangrenosum.
-
CLINICAL_TRIALS study record update · 2025-07-17Post-marketing Observational Study for Humira in Participants Diagnosed With Pyoderma Gangrenosum (PG)
-
CLINICAL_TRIALS study record update · 2025-07-08A Phase II Open Label Study of Xilonix in Subjects With Pyoderma Gangrenosum
-
CLINICAL_TRIALS study record update · 2025-06-27Novel Treatment of Pyoderma Gangrenosum With Deucravacitinib
-
CLINICAL_TRIALS study record update · 2025-05-13Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)
-
CLINICAL_TRIALS study record update · 2024-09-19Hyperbaric Oxygen Therapy for Pyoderma Gangrenosum As a New Treatment Strategy
-
CLINICAL_TRIALS study record update · 2023-09-14Open Label Exploratory Phase IIa Trial to Investigate the Safety and Efficacy of IFX-1 in Treating Patients With Pyoderma Gangrenosum (OPTIMA)
-
CLINICAL_TRIALS study record update · 2023-04-12Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma Gangrenosum
-
CLINICAL_TRIALS study record update · 2023-03-20Phase 0/1 Topical Application of the Monoclonal Antibody (Mab) sB24M in Patients With Severe Pyoderma
-
CLINICAL_TRIALS study record update · 2022-06-06An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum
-
CLINICAL_TRIALS study record update · 2022-03-23Expression of the JAK-STAT Signaling Pathway in Pyoderma Gangrenosum Pathological Biopsy
-
CLINICAL_TRIALS study record update · 2022-02-15Multi Center, Open Label Pilot Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum
-
CLINICAL_TRIALS study record update · 2021-06-11A Phase 2a, Open-label, Proof of Concept Study to Determine the Efficacy and Safety of Etrasimod (APD334) in Patients With Pyoderma Gangrenosum
-
CLINICAL_TRIALS study record update · 2021-05-28The Efficacy and Safety of Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum
-
CLINICAL_TRIALS study record update · 2021-03-09A Phase 3 Multicenter, Open-Label, Single Arm Study of the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Subjects in Japan
-
CLINICAL_TRIALS study record update · 2019-12-20A Multi-Center, Open Label Pilot Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum (HUM 04-37)
-
CLINICAL_TRIALS study record update · 2018-08-20Retrospective Multicenter Observational Study on the Clinical Features, Comorbidities and Pathologies Associated With Pyoderma Gangrenosum in Patients Diagnosed With This Pathology Between 2000 and 2015